The actual treatment package matters more than a shortened group name.
The randomized endoscopy report compared 272 patients assigned to regimens described as propofol-based versus pethidine–midazolam. Its methods summary included midazolam and ketamine in the propofol-based group. Satisfaction and recovery favored that group, while reported complications were more frequent; no serious events were observed.
This was not a clean comparison of propofol alone against midazolam alone. Differing co-medications prevent assigning every difference to one drug. Statistical significance of a small recovery-time difference does not automatically establish major clinical importance or superior overall safety.
For a procedural opinion, reconstruct every active agent, dose and rescue treatment. Separate satisfaction, sedation quality, recovery and complications. The paper illustrates how a headline or abbreviated group label can conceal multi-drug exposure and lead to incorrect attribution if the methods are not read.
Source reviewed: Comparison of the effects and side effects of sedation with propofol versus midazolam plus pethidine (PMC6173080). Forensic applications above are interpretive analysis of the supplied publication.
Related reading: Pediatric Bidirectional-Endoscopy Comparison Included Midazolam in Both Sedation Strategies.